SlideShare uma empresa Scribd logo
1 de 32
Baixar para ler offline
How Would  G o o g l e  Do Pharma? ,[object Object]
The Future…
Adventures of a Social Media Explorer
 
IamJohn MommaPugh
 
 
 
 
 
 
 
Twitter
 
What we tweet ,[object Object],[object Object],[object Object],[object Object]
Why Boehringer tweet Communications led initiative Clear vision of stakeholders - Journalists
 
Comparison JNJ 14%  Roche 15% Astra Zeneca US 18% Types of followers Media: Editors, writers, publishers:  38.4% http://twitteranalyzer.com/ June 2009
Traditional PR
“ Boehringer Ingelheim (BI's) - the German pharmaceutical company - has just completed the first-ever full bore social media campaign touting the results of its RE-LY® study - "the largest atrial fibrillation (AF) outcomes trial ever conducted."   John Mack Pharma Marketing Blog
[object Object]
YouTube
Content ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Effect on sales ,[object Object],[object Object]
Effect on sales ,[object Object],[object Object]
[object Object],[object Object],[object Object]
How Would  G o o g l e  Do Pharma?
R&D
Pricing
Self diagnosis
[object Object],[object Object],[object Object]
[object Object]

Mais conteúdo relacionado

Mais procurados

Future trends in pharma marketing 2016 copie
Future trends in pharma marketing 2016   copieFuture trends in pharma marketing 2016   copie
Future trends in pharma marketing 2016 copieJulien Dagher
 
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Len Starnes
 
Where does pharma marketing go from here
Where does pharma marketing go from hereWhere does pharma marketing go from here
Where does pharma marketing go from hereRichard Meyer
 
Decoding Mobile Medical Application Guidance from the FDA
Decoding Mobile Medical Application Guidance from the FDADecoding Mobile Medical Application Guidance from the FDA
Decoding Mobile Medical Application Guidance from the FDAGrey Matter Marketing
 
Redefining pharmacovigilance-with-social-media
Redefining pharmacovigilance-with-social-mediaRedefining pharmacovigilance-with-social-media
Redefining pharmacovigilance-with-social-mediaDheeraj Girdhani
 
The power of medical publications
The power of medical publicationsThe power of medical publications
The power of medical publicationshaithamo
 
Contradictions: The Changing World of Pharmaceutical Marketing
Contradictions: The Changing World of Pharmaceutical MarketingContradictions: The Changing World of Pharmaceutical Marketing
Contradictions: The Changing World of Pharmaceutical MarketingJim DeLash
 
PetCARE TV - The Veterinary Waiting Room Network
PetCARE TV - The Veterinary Waiting Room NetworkPetCARE TV - The Veterinary Waiting Room Network
PetCARE TV - The Veterinary Waiting Room NetworkBroadSign
 
Forecasting Audience Increase on Youtube
Forecasting Audience Increase on YoutubeForecasting Audience Increase on Youtube
Forecasting Audience Increase on YoutubeMatthew Rowe
 

Mais procurados (9)

Future trends in pharma marketing 2016 copie
Future trends in pharma marketing 2016   copieFuture trends in pharma marketing 2016   copie
Future trends in pharma marketing 2016 copie
 
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
 
Where does pharma marketing go from here
Where does pharma marketing go from hereWhere does pharma marketing go from here
Where does pharma marketing go from here
 
Decoding Mobile Medical Application Guidance from the FDA
Decoding Mobile Medical Application Guidance from the FDADecoding Mobile Medical Application Guidance from the FDA
Decoding Mobile Medical Application Guidance from the FDA
 
Redefining pharmacovigilance-with-social-media
Redefining pharmacovigilance-with-social-mediaRedefining pharmacovigilance-with-social-media
Redefining pharmacovigilance-with-social-media
 
The power of medical publications
The power of medical publicationsThe power of medical publications
The power of medical publications
 
Contradictions: The Changing World of Pharmaceutical Marketing
Contradictions: The Changing World of Pharmaceutical MarketingContradictions: The Changing World of Pharmaceutical Marketing
Contradictions: The Changing World of Pharmaceutical Marketing
 
PetCARE TV - The Veterinary Waiting Room Network
PetCARE TV - The Veterinary Waiting Room NetworkPetCARE TV - The Veterinary Waiting Room Network
PetCARE TV - The Veterinary Waiting Room Network
 
Forecasting Audience Increase on Youtube
Forecasting Audience Increase on YoutubeForecasting Audience Increase on Youtube
Forecasting Audience Increase on Youtube
 

Semelhante a How would Google do Pharma

Keys for pharma success
Keys for pharma successKeys for pharma success
Keys for pharma successpranaliparab
 
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...USP e Plexus
 
Deal with (LACK) of Regulations, Develop Best Practices
Deal with (LACK) of Regulations, Develop Best PracticesDeal with (LACK) of Regulations, Develop Best Practices
Deal with (LACK) of Regulations, Develop Best PracticesPharma Guy
 
Social Media Evaluation: March 12, 2010
Social Media Evaluation: March 12, 2010Social Media Evaluation: March 12, 2010
Social Media Evaluation: March 12, 2010jasonbritt
 
Healthcare Professionals and Social Media
Healthcare Professionals and Social MediaHealthcare Professionals and Social Media
Healthcare Professionals and Social MediaExL Pharma
 
II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies
II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New StrategiesII-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies
II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New StrategiesDr. Haxel Consult
 
BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends    BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends Joseph Pategou
 
Physicians' social networks in China
Physicians' social networks in ChinaPhysicians' social networks in China
Physicians' social networks in ChinaLen Starnes
 
Executive Summary:Regulation Issues on the development of Biosimilars
Executive Summary:Regulation Issues on the development of BiosimilarsExecutive Summary:Regulation Issues on the development of Biosimilars
Executive Summary:Regulation Issues on the development of BiosimilarsJoseph Pategou
 
Social Marketing The Roi
Social Marketing The RoiSocial Marketing The Roi
Social Marketing The RoiRalph Paglia
 
Research for ink 2011
Research for ink 2011Research for ink 2011
Research for ink 2011Ann Middleman
 
Bridging the Long/Short-Term Divide: The Role of Magazine Brands in the Digit...
Bridging the Long/Short-Term Divide: The Role of Magazine Brands in the Digit...Bridging the Long/Short-Term Divide: The Role of Magazine Brands in the Digit...
Bridging the Long/Short-Term Divide: The Role of Magazine Brands in the Digit...Louise Ioannou
 
Bridging the long/short term divide
Bridging the long/short term divideBridging the long/short term divide
Bridging the long/short term dividemagazinemediaBE
 
Balancing Act: How to Get the Most from your Advertising and Media Budget
Balancing Act: How to Get the Most from your Advertising and Media BudgetBalancing Act: How to Get the Most from your Advertising and Media Budget
Balancing Act: How to Get the Most from your Advertising and Media BudgetPaskill Stapleton & Lord
 
Social Media Analytics in Life Sciences
Social Media Analytics in Life SciencesSocial Media Analytics in Life Sciences
Social Media Analytics in Life SciencesIGATE Corporation
 
Social Media for Medical Technology Companies
Social Media for Medical Technology Companies Social Media for Medical Technology Companies
Social Media for Medical Technology Companies Grey Matter Marketing
 

Semelhante a How would Google do Pharma (20)

Keys for pharma success
Keys for pharma successKeys for pharma success
Keys for pharma success
 
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
 
Deal with (LACK) of Regulations, Develop Best Practices
Deal with (LACK) of Regulations, Develop Best PracticesDeal with (LACK) of Regulations, Develop Best Practices
Deal with (LACK) of Regulations, Develop Best Practices
 
Pesquisa Proof of Performance
Pesquisa Proof of PerformancePesquisa Proof of Performance
Pesquisa Proof of Performance
 
Social Media Evaluation: March 12, 2010
Social Media Evaluation: March 12, 2010Social Media Evaluation: March 12, 2010
Social Media Evaluation: March 12, 2010
 
Buzz Monitoring
Buzz MonitoringBuzz Monitoring
Buzz Monitoring
 
Healthcare Professionals and Social Media
Healthcare Professionals and Social MediaHealthcare Professionals and Social Media
Healthcare Professionals and Social Media
 
Is Pharma Ready
Is Pharma ReadyIs Pharma Ready
Is Pharma Ready
 
II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies
II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New StrategiesII-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies
II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies
 
BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends    BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends
 
Physicians' social networks in China
Physicians' social networks in ChinaPhysicians' social networks in China
Physicians' social networks in China
 
Social media and pharma
Social media and pharmaSocial media and pharma
Social media and pharma
 
Executive Summary:Regulation Issues on the development of Biosimilars
Executive Summary:Regulation Issues on the development of BiosimilarsExecutive Summary:Regulation Issues on the development of Biosimilars
Executive Summary:Regulation Issues on the development of Biosimilars
 
Social Marketing The Roi
Social Marketing The RoiSocial Marketing The Roi
Social Marketing The Roi
 
Research for ink 2011
Research for ink 2011Research for ink 2011
Research for ink 2011
 
Bridging the Long/Short-Term Divide: The Role of Magazine Brands in the Digit...
Bridging the Long/Short-Term Divide: The Role of Magazine Brands in the Digit...Bridging the Long/Short-Term Divide: The Role of Magazine Brands in the Digit...
Bridging the Long/Short-Term Divide: The Role of Magazine Brands in the Digit...
 
Bridging the long/short term divide
Bridging the long/short term divideBridging the long/short term divide
Bridging the long/short term divide
 
Balancing Act: How to Get the Most from your Advertising and Media Budget
Balancing Act: How to Get the Most from your Advertising and Media BudgetBalancing Act: How to Get the Most from your Advertising and Media Budget
Balancing Act: How to Get the Most from your Advertising and Media Budget
 
Social Media Analytics in Life Sciences
Social Media Analytics in Life SciencesSocial Media Analytics in Life Sciences
Social Media Analytics in Life Sciences
 
Social Media for Medical Technology Companies
Social Media for Medical Technology Companies Social Media for Medical Technology Companies
Social Media for Medical Technology Companies
 

Último

UiPath Studio Web workshop series - Day 6
UiPath Studio Web workshop series - Day 6UiPath Studio Web workshop series - Day 6
UiPath Studio Web workshop series - Day 6DianaGray10
 
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostKubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostMatt Ray
 
Machine Learning Model Validation (Aijun Zhang 2024).pdf
Machine Learning Model Validation (Aijun Zhang 2024).pdfMachine Learning Model Validation (Aijun Zhang 2024).pdf
Machine Learning Model Validation (Aijun Zhang 2024).pdfAijun Zhang
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7DianaGray10
 
Videogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfVideogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfinfogdgmi
 
Introduction to Quantum Computing
Introduction to Quantum ComputingIntroduction to Quantum Computing
Introduction to Quantum ComputingGDSC PJATK
 
Nanopower In Semiconductor Industry.pdf
Nanopower  In Semiconductor Industry.pdfNanopower  In Semiconductor Industry.pdf
Nanopower In Semiconductor Industry.pdfPedro Manuel
 
Linked Data in Production: Moving Beyond Ontologies
Linked Data in Production: Moving Beyond OntologiesLinked Data in Production: Moving Beyond Ontologies
Linked Data in Production: Moving Beyond OntologiesDavid Newbury
 
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPA
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPAAnypoint Code Builder , Google Pub sub connector and MuleSoft RPA
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPAshyamraj55
 
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...DianaGray10
 
NIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopNIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopBachir Benyammi
 
Spring24-Release Overview - Wellingtion User Group-1.pdf
Spring24-Release Overview - Wellingtion User Group-1.pdfSpring24-Release Overview - Wellingtion User Group-1.pdf
Spring24-Release Overview - Wellingtion User Group-1.pdfAnna Loughnan Colquhoun
 
9 Steps For Building Winning Founding Team
9 Steps For Building Winning Founding Team9 Steps For Building Winning Founding Team
9 Steps For Building Winning Founding TeamAdam Moalla
 
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdfJamie (Taka) Wang
 
Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Adtran
 
UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8DianaGray10
 
Do we need a new standard for visualizing the invisible?
Do we need a new standard for visualizing the invisible?Do we need a new standard for visualizing the invisible?
Do we need a new standard for visualizing the invisible?SANGHEE SHIN
 
RAG Patterns and Vector Search in Generative AI
RAG Patterns and Vector Search in Generative AIRAG Patterns and Vector Search in Generative AI
RAG Patterns and Vector Search in Generative AIUdaiappa Ramachandran
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Will Schroeder
 
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfIaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfDaniel Santiago Silva Capera
 

Último (20)

UiPath Studio Web workshop series - Day 6
UiPath Studio Web workshop series - Day 6UiPath Studio Web workshop series - Day 6
UiPath Studio Web workshop series - Day 6
 
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostKubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
 
Machine Learning Model Validation (Aijun Zhang 2024).pdf
Machine Learning Model Validation (Aijun Zhang 2024).pdfMachine Learning Model Validation (Aijun Zhang 2024).pdf
Machine Learning Model Validation (Aijun Zhang 2024).pdf
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7
 
Videogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfVideogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdf
 
Introduction to Quantum Computing
Introduction to Quantum ComputingIntroduction to Quantum Computing
Introduction to Quantum Computing
 
Nanopower In Semiconductor Industry.pdf
Nanopower  In Semiconductor Industry.pdfNanopower  In Semiconductor Industry.pdf
Nanopower In Semiconductor Industry.pdf
 
Linked Data in Production: Moving Beyond Ontologies
Linked Data in Production: Moving Beyond OntologiesLinked Data in Production: Moving Beyond Ontologies
Linked Data in Production: Moving Beyond Ontologies
 
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPA
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPAAnypoint Code Builder , Google Pub sub connector and MuleSoft RPA
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPA
 
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
 
NIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopNIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 Workshop
 
Spring24-Release Overview - Wellingtion User Group-1.pdf
Spring24-Release Overview - Wellingtion User Group-1.pdfSpring24-Release Overview - Wellingtion User Group-1.pdf
Spring24-Release Overview - Wellingtion User Group-1.pdf
 
9 Steps For Building Winning Founding Team
9 Steps For Building Winning Founding Team9 Steps For Building Winning Founding Team
9 Steps For Building Winning Founding Team
 
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
 
Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™
 
UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8
 
Do we need a new standard for visualizing the invisible?
Do we need a new standard for visualizing the invisible?Do we need a new standard for visualizing the invisible?
Do we need a new standard for visualizing the invisible?
 
RAG Patterns and Vector Search in Generative AI
RAG Patterns and Vector Search in Generative AIRAG Patterns and Vector Search in Generative AI
RAG Patterns and Vector Search in Generative AI
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
 
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfIaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
 

How would Google do Pharma

Notas do Editor

  1. We tweet links to our press releases because they have the relevant disclaimers and have been through the appropriate approval processes. We link to press packs and other sources of information on our websites We link to articles written by journalists that we find interesting or relevant. We ask questions, engage in dialogue and try to learn from those that we follow.
  2. I work in Communications or PR, and I’m clear who my customers are: journalists. Twitter provides me with a channel on which I can communicate with journalists. It’s a channel on which I can publish my messages but also listen to there’s. The way our media institutions work now, is much different from just a few years ago. For example, news delivery has changed. Paper newspapers sales have dwindled, advertising profits are down and online offerings have taken over as the key point of news access. The way news is collected has also changed. Citizen journalists or bloggers, are either going to break the story or be part of the process. Turn around time is quicker, the content needs to be richer with video and imagery and dialogue is becoming increasingly important. News stories are breaking on Twitter and being discussed on Twitter, and we believe it is important to be part of that dialogue.
  3. I asked my followers why they use Twitter. Diana Spencer UK journalist tweeted me: I find Twitter useful for getting the latest news in pharma, so regular updates of any product launches, approvals etc She goes on to say in another tweet: or maybe company comments in response to wider events, would be very handy!
  4. This is the most important measure of success: How many of our followers are journalists. We don’t have a perfect way to measure this yet and its reliant upon the tags users employ in their description. According to the free tool Twitter Analyzer: 38% of the people who follow us (ie people who have chosen to receive our messages) are either editors, writers or publishers. Is this normal To test I benchmarked against other pharma companies. JNJ with 14%, Roche with 15% and Astra Zeneca US with 18%. Now, of course this doesn’t take into account who they are targeting, and it’s a guide only.
  5. Which leads me on to the following point. Don’t forget traditional methods. They still work. Include your twitter profile on press releases, websites and email signatures. Boehringer have been successful in attracting media attention for our Twitter activities: It also helps win approval internally but also attracts new followers.
  6. I asked my followers why they use Twitter. Diana Spencer UK journalist tweeted me: I find Twitter useful for getting the latest news in pharma, so regular updates of any product launches, approvals etc She goes on to say in another tweet: or maybe company comments in response to wider events, would be very handy!